Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

80
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
80
Nephrons01:10

Nephrons

2.3K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.3K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

81
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
Dialysis01:27

Dialysis

288
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
288
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

174
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
174

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Implementation of an Integrated Pharmacology Curriculum in a Flipped, Small-Group, Case-Based, Pre-Clerkship Medical Curriculum Improved Student Performance.

Pharmacology research & perspectives·2026
Same author

Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease.

The Annals of pharmacotherapy·2024
Same author

Use of Continuous Glucose Monitoring in Older Adults: A Review of Benefits, Challenges and Future Directions.

TouchREVIEWS in endocrinology·2023
Same author

Diabetes: how to manage diabetic peripheral neuropathy.

Drugs in context·2022
Same author

The Impact of Implicit Biases in Pharmacy Education.

American journal of pharmaceutical education·2022

相关实验视频

Updated: Jun 23, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

548

慢性病的最新情况

Haley N Johnson1, Lalita Prasad-Reddy2

  • 1Pharmacy Practice, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy, St. Louis, MO, USA.

Journal of pharmacy practice
|June 15, 2024
PubMed
概括

有效的慢性病 (CKD) 管理需要严格控制血糖和血压. 最近的进展为CKD进展和贫血等并发症提供了新的治疗方法.

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 内部医学 内部医学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 慢性病 (CKD) 影响了美国14%的成年人,全球10%.
  • 血糖和血压控制是CKD的主要预防策略.
  • 新兴的疗法解决CKD进展和并发症,如贫血.

研究的目的:

  • 审查用于CKD评估和管理的最新证据和批准的药物.
  • 为管理CKD并发症提供最新的指导.
  • 为了支持医疗保健专业人员,特别是药剂师,在CKD患者的护理.

主要方法:

  • 对膜过率 (GFR) 测量方法的审查 (CKD-EPI 2021,cystatin C).
  • 分析病改善全球结果 (KDIGO) 和美国糖尿病协会 (ADA) 的指导方针.
  • 包含关于较新的CKD病原体和CMS覆盖范围的初级文献.

主要成果:

  • 较新的药物,包括矿物质皮质类受体抗剂和HIF-PH抑制剂,显示出有前途.
  • 更新的指导方针和测量方法有助于精确的CKD评估.
  • 提供了管理血压,血糖,CKD-矿物质骨疾病和贫血的检查清单.
关键词:
门诊护理服务 门诊护理慢性脏疾病 慢性脏疾病糖尿病病 糖尿病病内部医学是内科的专业.腎臟病學 (nephrology) 是一種醫學.

更多相关视频

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.2K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

相关实验视频

Last Updated: Jun 23, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

548
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.2K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

结论:

  • 目前的证据支持在CKD治疗中使用新型治疗剂.
  • 综合方法包括更新的指导方针和新的药物改善患者的结果.
  • 药剂师在管理CKD并发症和药物治疗方面发挥着至关重要的作用.